Skip to main content

Cookies and Privacy

We use cookies to improve your experience on our website. To find out more, read our updated Cookie policy, Privacy policy and Terms & Conditions

  1. 0cae52d3487daeff53f017ee46b0c928

    In the run-up to the first-ever Nobel Prize Summit, Project Syndicate – in partnership with the Nobel Foundation, the Potsdam Institute for Climate Impact Research, the US National Academy of Sciences, and the Stockholm Resilience Centre – is bringing together scientists, policymakers, business leaders, and Nobel laureates to analyze and debate some of the most pressing issues of our time. From climate change and biodiversity to inequality and digital disruption, the world’s leading thinkers will weigh in on the many dimensions of our increasingly urgent quest for a sustainable future.

This debate is brought to you in part by The Nobel Foundation and:

  • PIK2
  • NAOS
  • SRC+SU_BW_logo
  1. op_meng1_Patrick Pleulpicture alliance via Getty Images_pension Patrick Pleul/picture alliance via Getty Images

    Saving America’s Public Pensions

    Ben Meng

    Although the plight of major US public pension funds is nothing new, the gap between actual and assumed returns is widening faster than ever, owing to today's ultra-low interest rates. But these funds also have inherent advantages that, if used wisely, can place them on a much sounder financial footing.

    explains how struggling institutional investors can meet their goals in today's financial environment.
    1
  2. krishna1_EDDIE MULHOLLANDPOOLAFP via Getty Images_uk covid vaccine Eddie Mulholland/Pool/AFP via Getty Images

    Britain’s Vaccine Gamble

    Sanjeev Krishna & Yolanda Augustin

    During the pandemic, the UK has led the way in studying pharmaceutical interventions, with well-designed randomized controlled studies enabling vast improvements in patient care globally. Yet, by deciding to increase the gap between vaccine doses, the country's government has effectively abandoned this evidence-based approach. 

    consider the risks of delaying the second dose of the COVID-19 inoculation.
    0

Edit Newsletter Preferences

Set up Notification

To receive email updates regarding this {entity_type}, please enter your email below.

If you are not already registered, this will create a PS account for you. You should receive an activation email shortly.